Drug-coated balloon treatment of in-stent restenosis in complex severe cardiac allograft vasculopathy

Cardiac allograft vasculopathy (CAV) is a leading cause of late graft failure with limited revascularization options and high rates of in-stent restenosis (ISR). This report details a 33-year-old heart transplant recipient with progressive CAV that underwent multiple prior revascularizations, includ...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Tolulope Popoola, MD, Madhan Shanmugasundaram, MD, Elizabeth Juneman, MD, Deepak Acharya, MD, MSPH
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2026-08-01
Rangatū:	JHLT Open
Ngā marau:	cardiac allograft vasculopathy heart transplantation in-stent restenosis drug-coated balloon
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S295013342600128X
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Drug-coated balloon treatment of in-stent restenosis in complex severe cardiac allograft vasculopathy

Ngā tūemi rite